Jump Financial’s Cytokinetics CYTK Stock Holding History

Jump Financial’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-151,290	Closed	-$5M	–	1853
2025 Q2	$5M	Buy	+151,290	New	+$5.26M	0.06%	418
2023 Q4	–	Sell	-13,085	Closed	-$385K	–	1870
2023 Q3	$385K	Buy	13,085 +1,845	+16%	+$61.4K	0.01%	1154
2023 Q2	$367K	Buy	+11,240	New	+$416K	0.01%	1192
2022 Q1	–	Sell	-27,503	Closed	-$1.25M	–	1617
2021 Q4	$1.25M	Buy	+27,503	New	+$1.06M	0.08%	318
2021 Q3	–	Sell	-17,352	Closed	-$343K	–	1173
2021 Q2	$343K	Buy	17,352 +4,753	+38%	+$112K	0.03%	614
2021 Q1	$293K	Buy	+12,599	New	+$269K	0.03%	615
2020 Q4	–	Sell	-23,900	Closed	-$517K	–	986
2020 Q3	$517K	Buy	+23,900	New	+$559K	0.1%	314

Other funds holding CYTK

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Jump Financial's CYTK Position: Q3 2025 in Review

Jump Financial sold out of Cytokinetics (CYTK) in Q3 2025, closing a stake of 151,290 shares — an estimated $5M sold.

Jump Financial first reported a position in CYTK in Q3 2020 and held it in 7 quarters. The position peaked at $5M in Q2 2025. 380 funds tracked by Wall St. Rank hold CYTK as of Q3 2025.

Jump Financial reported no remaining Cytokinetics position as of Q3 2025 after selling out during the quarter.
Jump Financial sold 151,290 Cytokinetics shares in Q3 2025, an estimated $5M.
Jump Financial first reported a position in Cytokinetics in Q3 2020 and held it in 7 quarters.
Jump Financial's Cytokinetics position peaked at $5M in Q2 2025.
380 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2025.

Based on Jump Financial's 13F filing for Q3 2025, filed 13 Nov 2025.